Literature DB >> 8328253

Signet-ring cell melanoma mimicking adenocarcinoma. A case report.

W Y Tsang1, J K Chan, L T Chow.   

Abstract

The fine needle aspiration findings in a lymph node involved by signet-ring cell melanoma, a very rare variant of malignant melanoma, are reported. The patient had a history of superficial spreading melanoma of the right foot, treated 10 years earlier by below-the-knee amputation. He presented with a right groin mass. Fine needle aspiration of the mass yielded poorly cohesive, large cells with eccentric nuclei and abundant, eosinophilic cytoplasm; many of them exhibited a signet-ring appearance. Melanin pigments were identified in a small proportion of tumor cells, and a diagnosis of metastatic melanoma was made. The subsequent lymph node excision revealed a metastatic tumor composed of polygonal and signet-ring cells that were positive for S-100 protein and HMB-45 but not cytokeratin. Nearly all reported cases of signet-ring cell melanoma occurred as metastatic or recurrent disease. It is important not to mistake signet-ring cell melanoma for adenocarcinoma in aspiration cytology, and a constellation of clinical features and of histochemical and immunohistochemical findings enables a correct diagnosis to be reached.

Entities:  

Mesh:

Year:  1993        PMID: 8328253

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  3 in total

1.  FNA diagnosis of malignant melanoma-recurrent and metastatic disease.

Authors:  Kiran Alam; Anshu Jain; Meher Aziz; Aroonima Misra
Journal:  BMJ Case Rep       Date:  2012-11-14

2.  Conjunctival malignant melanoma: A rare variant and review of important diagnostic and therapeutic considerations.

Authors:  Danah H Albreiki; Steven M Gilberg; James P Farmer
Journal:  Saudi J Ophthalmol       Date:  2012-04

3.  Signet-ring cell melanoma with sentinel lymph node metastasis: A case report with immunohistochemical analysis and review of the clinicopathological features.

Authors:  Mitsuaki Ishida; Muneo Iwai; Keiko Yoshida; Akiko Kagotani; Hidetoshi Okabe
Journal:  Oncol Lett       Date:  2013-11-07       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.